1. NON-INTERVENTIONAL (NI) DRUG STUDY PROTOCOL STUDY OF THE UTILIZATION PATTERN OF APIXABAN IN THE NETHERLANDS 2.  Ibrahim Y. Mahamoud  Helene Saban  Ravi Kasula…

1. Antiplatelets & Fibrinolytics HARSHIT SHETH 2. Thrombosis • Arterial Thrombosis : – Adherence of platelets to arterial walls - White in color - Often associated…

1. Council for High Blood Pressure Research Stroke Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and on behalf of the American Heart Association…

Slide 1 Slide 2 Title Rivaroxaban Versus Warfarin in Nonvalvular Atrial Fibrillation Clinical Trial Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with…

Slide 1 Slide 2 AHA/ASA Guideline Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack: A Guideline for Healthcare Professionals From…

Slide 1Transcatheter LAA Occlusion Ahmed A. Khattab Cardiology Bern – Switzerland Slide 2 Patients with AF have a 5-fold higher risk of stroke >87% of strokes are thromboembolic…

Slide 1Percutaneous Closure of the Left Atrial Appendage versus Warfarin Therapy for Prevention of Stroke in Patients with Atrial Fibrillation: A Randomized Non-Inferiority…

Slide 1Matthew W. Sherwood, Anne Hellkamp, Manesh R. Patel, Jonathan P. Piccini, Yuliya Lokhnygina, James Douketis, Richard C. Becker, Kenneth W. Mahaffey, Keith A. A. Fox,…

Slide 1Debbie L. Cardell, MD Div Gen Med UTHSCSA2/29/08 Anticoagulation Debbie L. Cardell, MD Asst. Clinical Prof of Medicine Medical Director UHC-D Anticoagulation Clinic…

Slide 1NOAC but NICE Conference 16 th July 2013 Slide 2 Stroke Prevention in Atrial Fibrillation. NICE, NOACS and the future Dr John Duffy Stroke Consultant LTC Clinical…